Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP432332.RAlYpkfRmxEQ-jcBPz1eolduQcpEpXGGqVoJcK7y49Su0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP432332.RAlYpkfRmxEQ-jcBPz1eolduQcpEpXGGqVoJcK7y49Su0130_assertion type Assertion NP432332.RAlYpkfRmxEQ-jcBPz1eolduQcpEpXGGqVoJcK7y49Su0130_head.
- NP432332.RAlYpkfRmxEQ-jcBPz1eolduQcpEpXGGqVoJcK7y49Su0130_assertion description "[The IGHV4-34 gene was most frequently expressed in chronic lymphocytic leukemia (27.5%), whereas it was rarely found in leukemic chronic lymphoproliferative disorders (7.7%, P = 0.005).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP432332.RAlYpkfRmxEQ-jcBPz1eolduQcpEpXGGqVoJcK7y49Su0130_provenance.
- NP432332.RAlYpkfRmxEQ-jcBPz1eolduQcpEpXGGqVoJcK7y49Su0130_assertion evidence source_evidence_literature NP432332.RAlYpkfRmxEQ-jcBPz1eolduQcpEpXGGqVoJcK7y49Su0130_provenance.
- NP432332.RAlYpkfRmxEQ-jcBPz1eolduQcpEpXGGqVoJcK7y49Su0130_assertion SIO_000772 19220298 NP432332.RAlYpkfRmxEQ-jcBPz1eolduQcpEpXGGqVoJcK7y49Su0130_provenance.
- NP432332.RAlYpkfRmxEQ-jcBPz1eolduQcpEpXGGqVoJcK7y49Su0130_assertion wasDerivedFrom befree-20140225 NP432332.RAlYpkfRmxEQ-jcBPz1eolduQcpEpXGGqVoJcK7y49Su0130_provenance.
- NP432332.RAlYpkfRmxEQ-jcBPz1eolduQcpEpXGGqVoJcK7y49Su0130_assertion wasGeneratedBy ECO_0000203 NP432332.RAlYpkfRmxEQ-jcBPz1eolduQcpEpXGGqVoJcK7y49Su0130_provenance.